PMC:7170415 / 2091-2313
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 39 | 48-58 | Species | denotes | SARS–CoV-2 | Tax:2697049 |
| 40 | 62-73 | Species | denotes | respiratory | Tax:12814 |
| 41 | 123-131 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T13 | 48-52 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T14 | 123-131 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T19 | 0-222 | Sentence | denotes | Laboratory-based molecular assays for detecting SARS–CoV-2 in respiratory specimens are the current reference standard for COVID-19 diagnosis, but point-of-care technologies and serologic immunoassays are rapidly emerging. |